DADC
TMDX icon

D.A. Davidson & Co’s Transmedics TMDX Stock Holding History

D.A. Davidson & Co’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Sell
14,971
-363
-2% -$47.3K 0.01% 798
2025
Q4 		$1.87M Buy
15,334
+83
+0.5% +$10.4K 0.01% 683
2025
Q3 		$1.71M Buy
15,251
+2,846
+23% +$333K 0.01% 695
2025
Q2 		$1.66M Sell
12,405
-519
-4% -$57K 0.01% 666
2025
Q1 		$870K Buy
12,924
+1,442
+13% +$99.2K 0.01% 821
2024
Q4 		$716K Buy
11,482
+1,487
+15% +$138K 0.01% 895
2024
Q3 		$1.57M Buy
9,995
+53
+0.5% +$8.17K 0.01% 629
2024
Q2 		$1.5M Sell
9,942
-30
-0.3% -$3.6K 0.01% 609
2024
Q1 		$737K Buy
9,972
+752
+8% +$62K 0.01% 838
2023
Q4 		$728K Buy
9,220
+608
+7% +$36.7K 0.01% 812
2023
Q3 		$472K Buy
8,612
+59
+0.7% +$4.25K 0.01% 925
2023
Q2 		$718K Buy
8,553
+46
+0.5% +$3.52K 0.01% 805
2023
Q1 		$644K Buy
+8,507
New +$588K 0.01% 820

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.A. Davidson & Co's TMDX Position: Q1 2026 in Review

D.A. Davidson & Co reduced its Transmedics (TMDX) stake by 2.4% in Q1 2026, selling an estimated $47.3K and leaving 14,971 shares worth $1.49M. The position accounts for 0.01% of the portfolio, ranked #798.

D.A. Davidson & Co first reported a position in TMDX in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.87M in Q4 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • D.A. Davidson & Co held 14,971 shares of Transmedics worth $1.49M as of Q1 2026.
  • D.A. Davidson & Co sold 363 Transmedics shares in Q1 2026, an estimated $47.3K.
  • Transmedics made up 0.01% of D.A. Davidson & Co's portfolio in Q1 2026, its #798 holding.
  • D.A. Davidson & Co first reported a position in Transmedics in Q1 2023 and has held it in 13 quarters since.
  • D.A. Davidson & Co's Transmedics position peaked at $1.87M in Q4 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on D.A. Davidson & Co's 13F filing for Q1 2026, filed 5 May 2026.